22nd Century Group, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XXII research report →
Companywww.xxiicentury.com
22nd Century Group, Inc. , an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies.
- CEO
- Lawrence D. Firestone
- IPO
- 2011
- Employees
- 56
- HQ
- Mocksville, NY, US
Price Chart
Valuation
- Market Cap
- $101.82K
- P/E
- -0.09
- P/S
- 0.01
- P/B
- 0.02
- EV/EBITDA
- 0.79
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -36.66%
- Op Margin
- -133.86%
- Net Margin
- -44.90%
- ROE
- -25.03%
- ROIC
- -52.27%
Growth & Income
- Revenue
- $7.05M · -40.65%
- Net Income
- $-5,054,000 · 66.67%
- EPS
- $-52.88 · 99.91%
- Op Income
- $-11,416,000
- FCF YoY
- 40.73%
Performance & Tape
- 52W High
- $365.70
- 52W Low
- $0.51
- 50D MA
- $2.10
- 200D MA
- $14.23
- Beta
- 0.77
- Avg Volume
- 1.34M
Get TickerSpark's AI analysis on XXII
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 10, 25 | Arno Andrew | other | 51,888 |
| Nov 10, 25 | Arno Andrew | other | 17,295 |
| Nov 10, 25 | MANFREDONIA ROBERT P | other | 97,288 |
| Nov 10, 25 | MANFREDONIA ROBERT P | other | 32,429 |
| Nov 10, 25 | Staffeldt Jonathan | other | 111,439 |
| Nov 10, 25 | Staffeldt Jonathan | other | 37,146 |
| Nov 10, 25 | Marion Arvil S. | other | 97,288 |
| Nov 10, 25 | Marion Arvil S. | other | 32,429 |
| Nov 10, 25 | SALHANY LUCILLE S | other | 33,020 |
| Nov 10, 25 | SALHANY LUCILLE S | other | 11,006 |
Our XXII Coverage
We haven't published any research on XXII yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate XXII Report →